|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q3 FY2012
As of Sep 30, 2012
|
Q1 FY2012
As of Mar 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
Q3 FY2011
As of Sep 30, 2011
|
Q2 FY2011
As of Jun 30, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||
| Cash and due from banks | |||||||||||||||||
| Interest-earning deposits | |||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||
| Investment securities available for sale (AFS) | |||||||||||||||||
| Investment securities held to maturity (HTM) | |||||||||||||||||
| Loans held for sale | |||||||||||||||||
| Loans held for investment | |||||||||||||||||
| Less: Allowance for loan losses | |||||||||||||||||
| Loans held for investment, net | |||||||||||||||||
| Other real estate owned (OREO), net | |||||||||||||||||
| Premises and equipment, net | |||||||||||||||||
| Federal Home Loan Bank stock - at cost | |||||||||||||||||
| Mortgage servicing rights (MSRs), net | |||||||||||||||||
| Accrued interest receivable | |||||||||||||||||
| Deferred tax asset, net | |||||||||||||||||
| Other assets | |||||||||||||||||
| Total assets | |||||||||||||||||
| Liabilities and Stockholders' Equity | |||||||||||||||||
| Deposits | |||||||||||||||||
| Non-interest bearing | |||||||||||||||||
| Interest bearing | |||||||||||||||||
| Total deposits | |||||||||||||||||
| Other borrowed funds | |||||||||||||||||
| Accrued interest payable | |||||||||||||||||
| Accrued taxes, insurance and employee related expenses | |||||||||||||||||
| Other liabilities | |||||||||||||||||
| Total liabilities | |||||||||||||||||
| Preferred stock: par value $0.01, authorized 100,000 shares, none outstanding | |||||||||||||||||
| Common stock: par value $0.01, 11,900,000 shares authorized, 9,608,957 and 9,552,094 shares issued, 9,597,392 and 9,547,587 shares outstanding at December 31, 2015 and 2014, respectively | |||||||||||||||||
| Additional paid-in capital | |||||||||||||||||
| Retained earnings | |||||||||||||||||
| Accumulated other comprehensive loss related to AFS securities | |||||||||||||||||
| Accumulated other comprehensive loss related to other than temporary impairment (OTTI) securities - non-credit factors | |||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||
| Deferred compensation obligation | |||||||||||||||||
| Treasury stock: 11,565 shares and 4,507 shares at December 31, 2015 and 2014, respectively, at cost | |||||||||||||||||
| Total stockholders' equity | |||||||||||||||||
| Total liabilities and stockholders' equity | |||||||||||||||||
Loading...
